APA

Leon M. B., Mauri L., Popma J. J., Cutlip D. E., Nikolsky E., O'Shaughnessy C., Overlie P. A., McLaurin B. T., Solomon S. L., Douglas J. S., Ball M. W., Caputo R. P., Jain A., Tolleson T. R., Reen B. M., Kirtane A. J., Fitzgerald P. J., Thompson K. & Kandzari D. E. (20100316). A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. : Journal of the American College of Cardiology.

Chicago

Leon Martin B, Mauri Laura, Popma Jeffrey J, Cutlip Donald E, Nikolsky Eugenia, O'Shaughnessy Charles, Overlie Paul A, McLaurin Brent T, Solomon Stuart L, Douglas John S, Ball Michael W, Caputo Ronald P, Jain Ash, Tolleson Thaddeus R, Reen Bernard M, Kirtane Ajay J, Fitzgerald Peter J, Thompson Kweli and Kandzari David E. 20100316. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. : Journal of the American College of Cardiology.

Harvard

Leon M. B., Mauri L., Popma J. J., Cutlip D. E., Nikolsky E., O'Shaughnessy C., Overlie P. A., McLaurin B. T., Solomon S. L., Douglas J. S., Ball M. W., Caputo R. P., Jain A., Tolleson T. R., Reen B. M., Kirtane A. J., Fitzgerald P. J., Thompson K. and Kandzari D. E. (20100316). A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. : Journal of the American College of Cardiology.

MLA

Leon Martin B, Mauri Laura, Popma Jeffrey J, Cutlip Donald E, Nikolsky Eugenia, O'Shaughnessy Charles, Overlie Paul A, McLaurin Brent T, Solomon Stuart L, Douglas John S, Ball Michael W, Caputo Ronald P, Jain Ash, Tolleson Thaddeus R, Reen Bernard M, Kirtane Ajay J, Fitzgerald Peter J, Thompson Kweli and Kandzari David E. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. : Journal of the American College of Cardiology. 20100316.